Status:
UNKNOWN
Efficacy and Safety of Using Granules Dendrobii for the Treatment of Chronic Atrophic Gastritis
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Atrophic Gastritis
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Chronic atrophic gastritis (CAG) is a common and frequently-occurring disease, characterized by atrophy of gastric mucosal epithelium and glands, thinning of the mucosa, thickening of the submucosal m...
Detailed Description
Chronic atrophic gastritis, (CAG) is a common and frequently-occurring disease, characterized by atrophy of gastric mucosal epithelium and glands, thinning of the mucosa, thickening of the submucosal ...
Eligibility Criteria
Inclusion
- Fulfill the diagnosis of chronic atrophic gastritis;
- TCM syndrome differentiation is deficiency of both qi and yin;
- Aged between 18 and 65 years old, regardless of gender;
- Volunteer to participate in this clinical trial and sign an informed consent form.
Exclusion
- Patients with peptic ulcer, acid reflux, etc. who need PPI treatment;
- Patients with high-grade intraepithelial neoplasia of gastric mucosa or suspected malignant transformation in pathological diagnosis;
- Those who have received anti-HP treatment and related treatments in the past two weeks;
- Diabetic patients;
- Patients with severe heart, liver, kidney, lung, blood system diseases, abnormal renal function Cr test with clinical significance, and liver function ALT ≥ 1.5 times the upper limit of the normal reference value;
- People with allergies or a history of allergies to multiple drugs (two or more or the known ingredients in the drug);
- Those planning to become pregnant, pregnant or breast-feeding;
- Patients with mental illness;
- Those who have participated in other drug clinical trials within the past 3 months;
- The investigator believes that it is not suitable to participate in this clinical trial.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05209633
Start Date
November 1 2022
End Date
August 1 2024
Last Update
November 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Hong Kong, Hong Kong